Stem cells that transform to beating cardiomyocytes
CA 2464088 A1 · Owner: Gopal, Thiru V. · Inventors: Epstein, Neal D.; Winitsky, Steve O.; Gopal, Thiru V.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed herein is a novel isolated population of stem cells called spoc , cells, that can be induced eitherin vivo or in vitro, to differentiate into cardiomyocytes. Methods are disclosed herein to differentiate the spoc cells and to utilize these spoc cells for screening agents that affect cardiomyocytes. Methods are also provided herein to utilize spoc cells in therapeutic applications for the treatment of myocardial defects such as , areas of ischemic or traumatic damage.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 22, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 22, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 22, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.